Perceptions of the relative harmfulness of marijuana and alcohol among adults in Oregon.
#85 Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
# Article Significance for Clinicians and Patients
Understanding how patients perceive the comparative risks of marijuana versus alcohol is critical for clinicians conducting substance use assessments and counseling, as these perceptions directly influence patient decision-making and treatment engagement. Clinicians in states like Oregon with legal cannabis need evidence about public risk perception to identify gaps between patient beliefs and clinical evidence when advising on substance use harms. This knowledge helps clinicians tailor educational interventions and address misconceptions that may lead patients to substitute or co-use cannabis and alcohol in ways that increase overall health risks.
This cross-sectional survey examined Oregon adults’ perceptions of the relative health risks of marijuana versus alcohol, finding that a substantial proportion of respondents viewed marijuana as less harmful than alcohol or equally harmful. The study is relevant to clinical practice because patient risk perception significantly influences treatment decisions, medication adherence, and disclosure patterns during medical history taking. As cannabis legalization expands and products become more accessible, clinicians should recognize that many patients may underestimate cannabis risks relative to alcohol, potentially affecting counseling effectiveness and informed consent discussions. The findings highlight a gap between public perception and clinical evidence regarding cannabis risks such as cannabis use disorder, impaired cognition, and respiratory effects. Clinicians should proactively educate patients about cannabis-specific harms while acknowledging legitimate concerns about alcohol, using evidence-based comparative risk communication to support shared decision-making in cannabis use and therapeutic contexts.
“What this data tells us is that patients and the general public have largely caught up to the clinical evidence: alcohol causes more measurable organ damage, higher addiction potential, and greater mortality risk than cannabis, yet we’ve spent decades treating them as moral equivalents in policy. In my practice, I’m seeing patients make more informed choices when we simply present the comparative pharmacology without ideology, and that shift alone improves our ability to have honest conversations about actual risk.”
? Public perception data from Oregon showing that many adults view marijuana as less harmful than alcohol has important implications for clinical counseling, even as we await more definitive long-term safety comparisons. While some evidence suggests lower acute toxicity and overdose risk with cannabis compared to alcohol, this perception gap may not fully account for cannabis-related risks including cannabis hyperemesis syndrome, impaired driving, respiratory effects, and potential impacts on cognitive development in younger users. Clinicians should recognize that patients may arrive with preformed beliefs about relative harmfulness based on community norms rather than clinical evidence, which can influence their receptiveness to risk counseling. The gap between public perception and evolving clinical evidence underscores the need for individualized, non-judgmental conversations that acknowledge valid concerns about alcohol while clearly discussing cannabis-specific harms and drug interactions, particularly for patients with psychiatric histories or those taking medications metabolized through the same hepatic pathways. In practice,
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
FAQ
This News item was assembled from structured source metadata and pipeline scoring.
Have thoughts on this? Share it:
